Harlan R. Barker
发表
M. Nykter,
M. Rämet,
Meri I E Uusi-Mäkelä,
2018,
PloS one.
Harlan R. Barker,
V. Hytönen,
S. Parkkila,
2018,
Applied and Environmental Microbiology.
C. Supuran,
D. Vullo,
Harlan R. Barker,
2015,
Parasites & Vectors.
Harlan R. Barker,
V. Hytönen,
S. Parkkila,
2016,
Parasites & Vectors.
Harlan R. Barker,
S. Parkkila,
M. Tolvanen,
2020,
bioRxiv.
C. Supuran,
Harlan R. Barker,
S. Parkkila,
2022,
Journal of enzyme inhibition and medicinal chemistry.
C. Ortutay,
Harlan R. Barker,
S. Parkkila,
2013,
Bioorganic & medicinal chemistry.
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
Harlan R. Barker,
S. Parkkila,
2020,
bioRxiv.
Harlan R. Barker,
H. Haapasalo,
S. Parkkila,
2018,
BMC Cancer.
C. Ortutay,
C. Supuran,
M. Hilvo,
2017,
PeerJ.
L. Dubois,
Harlan R. Barker,
D. Matulis,
2019,
Carbonic Anhydrase as Drug Target.
Harlan R. Barker,
V. Hytönen,
S. Parkkila,
2014,
Parasites & Vectors.
Harlan R. Barker,
V. Hytönen,
S. Parkkila,
2022,
Malaria journal.
C. Supuran,
Harlan R. Barker,
S. Parkkila,
2015,
Journal of enzyme inhibition and medicinal chemistry.
Harlan R. Barker,
S. Parkkila,
M. Tolvanen,
2022
.
P. Lambin,
L. Dubois,
C. Supuran,
2019,
Journal of enzyme inhibition and medicinal chemistry.
C. Supuran,
Harlan R. Barker,
V. Hytönen,
2022,
Applied Microbiology and Biotechnology.
Harlan R. Barker,
S. Parkkila,
R. Z. Emameh,
2019,
Carbonic Anhydrases.
Genotyping determination of Acanthamoeba strains: an original study and a systematic review in Iran.
Harlan R. Barker,
M. Rahimi,
R. Z. Emameh,
2019,
Journal of water and health.
C. Supuran,
Harlan R. Barker,
S. Parkkila,
2016,
Journal of enzyme inhibition and medicinal chemistry.
P. Lambin,
L. Dubois,
C. Supuran,
2018,
Journal of enzyme inhibition and medicinal chemistry.
Harlan R. Barker,
C. Heckman,
D. Ungureanu,
2019,
Oncogene.
W. Sly,
Harlan R. Barker,
A. Waheed,
2022,
Physiological reviews.
Harlan R. Barker,
S. Parkkila,
Pei-wen Pan,
2016,
Transgenic Research.
W. Sly,
S. Pastoreková,
Harlan R. Barker,
2017,
Experimental &Molecular Medicine.
Harlan R. Barker,
M. Parikka,
A. Saltari,
2017,
International journal of molecular sciences.
O. Kallioniemi,
Harlan R. Barker,
D. Ungureanu,
2020,
Cell Death & Disease.
Harlan R. Barker,
D. Ungureanu,
A. Murumägi,
2021,
Cancers.
C. Supuran,
Harlan R. Barker,
M. Parikka,
2017,
Journal of enzyme inhibition and medicinal chemistry.
Harlan R. Barker,
S. Parkkila,
A. Aspatwar,
2015
.
M. Rämet,
C. Ortutay,
Harlan R. Barker,
2015,
PloS one.
Harlan R. Barker,
D. Ungureanu,
Robert Perttilä,
2018,
European journal of haematology.
Harlan R. Barker,
D. Ungureanu,
H. Karvonen,
2018,
FEBS letters.
Harlan R. Barker,
D. Ungureanu,
H. Karvonen,
2019,
Cells.
H. Uusitalo,
Harlan R. Barker,
T. Järvinen,
2018,
Experimental eye research.
C. Ortutay,
Harlan R. Barker,
S. Parkkila,
2014,
Parasites & Vectors.
Harlan R. Barker,
T. Järvinen,
S. Parkkila,
2018,
Experimental dermatology.
Harlan R. Barker,
S. Parkkila,
Pei-wen Pan,
2016,
Transgenic Research.
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
Harlan R. Barker,
S. Parkkila,
2020,
bioRxiv.